Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Mallinckrodt
McKinsey
Harvard Business School
Baxter
Merck
Moodys

Last Updated: September 26, 2022

Alcon Company Profile


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


Summary for Alcon

Drugs and US Patents for Alcon

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Alcon MAXIDEX dexamethasone sodium phosphate OINTMENT;OPHTHALMIC 083342-001 Approved Prior to Jan 1, 1982 DISCN No No See Plans and Pricing See Plans and Pricing
Alcon Pharma ZADITOR ketotifen fumarate SOLUTION/DROPS;OPHTHALMIC 021066-002 Oct 19, 2006 DISCN Yes No See Plans and Pricing See Plans and Pricing
Alcon Pharms Ltd NEOMYCIN SULFATE-DEXAMETHASONE SODIUM PHOSPHATE dexamethasone sodium phosphate; neomycin sulfate SOLUTION/DROPS;OPHTHALMIC 062714-001 Jul 21, 1986 DISCN No No See Plans and Pricing See Plans and Pricing
Alcon Pharms Ltd ZADITOR ketotifen fumarate SOLUTION/DROPS;OPHTHALMIC 077200-001 Sep 2, 2008 OTC No Yes See Plans and Pricing See Plans and Pricing
Alcon Pharms Ltd SULFACETAMIDE SODIUM sulfacetamide sodium SOLUTION/DROPS;OPHTHALMIC 089068-001 May 5, 1987 DISCN No No See Plans and Pricing See Plans and Pricing
Alcon STATROL neomycin sulfate; polymyxin b sulfate SOLUTION/DROPS;OPHTHALMIC 062339-001 Nov 30, 1984 DISCN No No See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for Alcon

Paragraph IV (Patent) Challenges for ALCON drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Ophthalmic Solution 0.00% ➤ Subscribe 2008-11-28
➤ Subscribe Ophthalmic Solution 0.03% ➤ Subscribe 2004-12-23

Supplementary Protection Certificates for Alcon Drugs

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
1920764 C01920764/01 Switzerland See Plans and Pricing PRODUCT NAME: TRAVOPROST; REGISTRATION NUMBER/DATE: SWISSMEDIC 55910 22.05.2002
2365988 LUC00061 Luxembourg See Plans and Pricing PRODUCT NAME: PATIROMER SORBITEX CALCIUM ET TOUS LES SELS ET DERIVES DE CELUI-CI; AUTHORISATION NUMBER AND DATE: EU/1/17/1179 20170721
2957286 LUC00094 Luxembourg See Plans and Pricing PRODUCT NAME: PATIROMER SORBITEX CALCIUM; AUTHORISATION NUMBER AND DATE: EU/1/17/1179 20170721
2957286 132019000000021 Italy See Plans and Pricing PRODUCT NAME: PATIROMER SORBITEX CALCIUM E QUALSIASI SUO SALE O DERIVATO(VELTASSA); AUTHORISATION NUMBER(S) AND DATE(S): EU/1/17/1179, 20170721
1280520 C01280520/01 Switzerland See Plans and Pricing PRODUCT NAME: TOBRAMYCIN; REGISTRATION NO/DATE: SWISSMEDIC-ZULASSUNG 60565 01.02.2012
0720599 CR 2014 00050 Denmark See Plans and Pricing PRODUCT NAME: EZETIMIBE AND ATORVASTATIN OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, INCLUDING ATORVASTATIN AS ATORVASTATIN CALCIUM TRIHYDRATE; REG. NO/DATE: DE/H/3895-3898/001-004/DC 20140910
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Boehringer Ingelheim
Mallinckrodt
Johnson and Johnson
Dow
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.